LB制药 LBRX
$42.01 +$3.92 (+10.29%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $42.50 +1.17%
开盘$38.53
昨收$38.09
当日区间$38.04 – $42.29
成交量480.3K
市值$1.36B
市盈率（TTM）41.4
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$53.92M-1,009.6% YoY
净利润-$51.60M-959.4% YoY
摊薄每股收益-$1.71-687.9% YoY
自由现金流-$37.99M-579.0% YoY
经营现金流-$37.63M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-75.0%
资产收益率-45.0%
投入资本回报率-76.9%
流动比率15.08
负债/资产比率8.1%
现金及投资$327.79M
总负债$4.37M
净现金（净负债）$323.42M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $53.92M | $22.10M | $30.40M | $13.87M | $5.25M |
| 销售及管理费用 | $9.77M | $7.46M | $13.66M | $5.39M | $2.83M |
| -管理费用 | $9.77M | $7.46M | $13.66M | $5.39M | $2.83M |
| 研发费用 | $44.15M | $14.65M | $16.74M | $8.48M | $2.42M |
| 营业利润 | -$53.92M | -$22.10M | -$30.40M | -$13.87M | -$5.25M |
| 非经营性利息净收入（支出） | $2.97M | $2.85M | $3.92M | $2.80M | $707,000.00 |
| 非经营性利息收入 | $2.97M | $2.85M | $3.92M | $2.80M | $707,000.00 |
| 其他收入（支出） | -$662,000.00 | $200,000.00 | $1.28M | -$401,000.00 | $983,000.00 |
| 证券出售收益 | -$662,000.00 | $200,000.00 | $1.28M | -$401,000.00 | $983,000.00 |
| 税前利润 | -$51.60M | -$19.05M | -$25.20M | -$11.47M | -$3.56M |
| 税费 | $0.00 | $0.00 | $1,000.00 | $1,000.00 | $0.00 |
| 净利润 | -$51.60M | -$19.05M | -$25.21M | -$11.47M | -$3.56M |
| 持续经营利润 | -$51.60M | -$19.05M | -$25.21M | -$11.47M | -$3.56M |
| 归属母公司净利润 | -$51.60M | -$19.05M | -$25.21M | -$11.47M | -$3.56M |
| 归属普通股股东净利润 | -$51.60M | -$19.05M | -$25.21M | -$11.47M | -$3.56M |
| 基本每股收益 | -$1.71 | -$0.67 | -$3.13 | -$0.45 | -$0.61 |
| 摊薄每股收益 | -$1.71 | -$0.67 | -$3.13 | -$0.45 | -$0.61 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $361.69M | $393.48M | $312.93M | $312.93M | $320.75M |
| 流动资产合计 | $355.30M | $389.07M | $308.43M | $308.43M | $316.40M |
| 现金及现金等价物与短期投资 | $327.79M | $365.64M | $295.21M | $295.21M | $314.48M |
| -现金及现金等价物 | $283.11M | $320.68M | $250.17M | $250.17M | $269.74M |
| -短期投资 | $44.68M | $44.96M | $45.04M | $45.04M | $44.74M |
| 预付资产 | $26.50M | $22.65M | $12.74M | $12.74M | – |
| 其他流动资产 | $1.01M | $787,000.00 | $478,000.00 | $478,000.00 | $1.92M |
| 非流动资产合计 | $6.39M | $4.41M | $4.50M | $4.50M | $4.35M |
| 固定资产净值 | $5.61M | $3.63M | $3.73M | $3.73M | $3.83M |
| -固定资产原值 | $6.21M | $4.13M | $4.15M | $4.15M | $4.17M |
| -累计折旧 | -$599,000.00 | -$502,000.00 | -$420,000.00 | -$420,000.00 | -$337,000.00 |
| 其他非流动资产 | $782,000.00 | $776,000.00 | $770,000.00 | $770,000.00 | $512,000.00 |
| 负债合计 | $29.35M | $14.79M | $11.62M | $11.62M | $10.53M |
| 流动负债合计 | $23.56M | $10.91M | $7.44M | $7.44M | $6.65M |
| 应付款 | $3.49M | $7.12M | $2.13M | $2.13M | $2.59M |
| -应付账款 | $3.49M | $7.12M | $2.13M | $2.13M | $2.59M |
| 一年内应计费用 | $16.43M | $1.71M | $2.39M | $2.39M | $1.33M |
| 短期债务及融资租赁负债 | $844,000.00 | $730,000.00 | $730,000.00 | $730,000.00 | $730,000.00 |
| -一年内到期融资租赁负债 | $844,000.00 | $730,000.00 | $730,000.00 | $730,000.00 | $730,000.00 |
| 非流动负债合计 | $5.78M | $3.88M | $4.18M | $4.18M | $3.88M |
| 长期债务及融资租赁负债 | $4.37M | $2.74M | $2.84M | $2.84M | $2.94M |
| -长期融资租赁负债 | $4.37M | $2.74M | $2.84M | $2.84M | $2.94M |
| 衍生产品负债 | $1.41M | $1.14M | $1.34M | $1.34M | $942,000.00 |
| 股东权益合计 | $332.35M | $378.69M | $301.31M | $301.31M | $310.22M |
| 股东权益 | $332.35M | $378.69M | $301.31M | $301.31M | $310.22M |
| 股本 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| -普通股 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| 资本公积 | $532.34M | $527.06M | $430.67M | $430.67M | $428.33M |
| 留存收益 | -$200.19M | -$148.58M | -$129.53M | -$129.53M | -$118.06M |
| 不影响留存收益的损益 | $186,000.00 | $208,000.00 | $168,000.00 | $168,000.00 | -$53,000.00 |
| 可转换优先证券 | – | – | $0.00 | $0.00 | $0.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$37.63M | -$23.29M | -$35.21M | -$18.10M | -$3.37M |
| 持续经营经营活动现金流净额 | -$37.63M | -$23.29M | -$35.21M | -$18.10M | -$3.37M |
| 持续经营净利润 | -$51.60M | -$19.05M | -$25.21M | -$11.47M | -$3.56M |
| 持续经营损益 | $662,000.00 | -$200,000.00 | -$1.27M | $409,000.00 | -$983,000.00 |
| 折旧、折耗与摊销 | $97,000.00 | $82,000.00 | $321,000.00 | $85,000.00 | $81,000.00 |
| 其他非现金项目 | $93,000.00 | $50,000.00 | $147,000.00 | $47,000.00 | $45,000.00 |
| 营运资金变动 | $8.29M | -$6.75M | -$13.65M | -$9.53M | -$97,000.00 |
| -应收款变动 | -$123,000.00 | $103,000.00 | -$268,000.00 | -$100,000.00 | -$208,000.00 |
| -预付资产变动 | -$4.07M | -$10.22M | -$12.34M | -$11.30M | -$1.37M |
| -应付账款及应计费用变动 | $12.54M | $3.46M | -$910,000.00 | $1.97M | $1.57M |
| -其他流动负债变动 | -$57,000.00 | -$99,000.00 | -$134,000.00 | -$98,000.00 | -$94,000.00 |
| 投资活动现金流净额 | $89,000.00 | -$32,000.00 | -$39.89M | -$40,000.00 | -$44.84M |
| 持续经营投资活动现金流净额 | $89,000.00 | -$32,000.00 | -$39.89M | -$40,000.00 | -$44.84M |
| 固定资产购置及出售净额 | -$363,000.00 | -$32,000.00 | -$52,000.00 | -$40,000.00 | $0.00 |
| 投资购置及出售净额 | $452,000.00 | $0.00 | -$39.84M | $0.00 | -$44.84M |
| 筹资活动现金流 | -$19,000.00 | $93.83M | $302.56M | -$1.17M | $303.73M |
| 持续经营筹资活动现金流净额 | -$19,000.00 | $93.83M | $302.56M | -$1.17M | $303.73M |
| 普通股发行净额 | $0.00 | $100.00M | $327.75M | $0.00 | $327.75M |
| 股票期权行使所得 | $48,000.00 | $29,000.00 | $247,000.00 | $0.00 | $247,000.00 |
| 其他筹资费用净额 | -$67,000.00 | -$6.20M | -$25.44M | -$1.17M | – |
| 期末现金余额 | $283.89M | $321.45M | $250.94M | $250.94M | $270.26M |
| 现金净变动 | -$37.56M | $70.51M | $227.47M | -$19.31M | $255.52M |
| 期初现金余额 | $321.45M | $250.94M | $23.48M | $270.26M | $14.73M |
| 自由现金流 | -$37.99M | -$23.32M | -$35.26M | -$18.14M | -$3.37M |
| 优先股发行净额 | – | – | $0.00 | $0.00 | – |
暂无评论——快来第一个聊聊 LBRX。
登录后参与讨论。